A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis.

  • Kurt-Wolfram Sühs
  • Katharina Hein
  • Muriel B Sättler
  • Anke Görlitz
  • Christoph Ciupka
  • Kerstin Scholz
  • Barbara Käsmann-Kellner
  • Panagiotis Papanagiotou
  • Nina Schäffler
  • Cordula Restemeyer
  • Diana Bittersohl
  • Andrea Hassenstein
  • Berthold Seitz
  • Wolfgang Reith
  • Klaus Fassbender
  • Reinhard Hilgers
  • Christoph Heesen
  • Mathias Bähr
  • Ricarda Diem

Abstract

Based on findings in animal models of autoimmune optic nerve inflammation, we have assessed the safety and efficacy of erythropoietin in patients presenting with a first episode of optic neuritis.

Bibliographical data

Original languageEnglish
Article number2
ISSN0364-5134
Publication statusPublished - 2012
pubmed 22926853